MedicarePartD.guide

A non-government resource built from CMS public data

Osteoporosis drugs on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Osteoporosis drugs by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
alendronategeneric FosamaxTier 2$1.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00Tier 2$6.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00Tier 1$5.00QL 30/30dTier 1$0.00QL 30/30d
risedronategeneric ActonelNot coveredNot coveredTier 2$3.00QL 1/30dNot coveredNot coveredNot coveredNot coveredTier 433%QL 1/28dNot coveredNot covered
ibandronategeneric BonivaTier 325%QL 1/28dTier 325%QL 1/30dTier 2$3.00QL 1/30dTier 318%QL 1/28dTier 317%QL 1/28dTier 319%QL 1/28dTier 320%QL 1/28dTier 433%QL 1/30dTier 318%QL 1/28dTier 3$45.00QL 1/28d
ProliadenosumabTier 432%QL 1/180dNot coveredNot coveredTier 434%QL 1/180dTier 430%QL 1/180dNot coveredTier 430%QL 1/180dNot coveredNot coveredTier 450%QL 1/180d
denosumab biosimilarsJubbonti, Ospomyv and othersNot coveredTier 431%QL 1/180dTier 440%QL 1/180dNot coveredNot coveredTier 434%QL 1/180dNot coveredTier 433%QL 1/180dTier 436%QL 1/180dNot covered
EvenityromosozumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ForteoteriparatideTier 5PA25%QL 2.24/28dNot coveredNot coveredTier 5PA26%QL 2.24/28dNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA33%QL 2.24/28d
teriparatidegeneric ForteoNot coveredTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dNot coveredTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%Tier 5PA31%QL 2.48/28dNot covered
TymlosabaloparatideNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%Tier 5PA31%QL 1.56/30dNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.